{"id":"gadovist","rwe":[],"tags":[],"safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[],"contraindications":[],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"trials":[],"_chembl":{"chemblId":"CHEMBL2218860","moleculeType":"Small molecule","molecularWeight":"604.72"},"aliases":["gadobutrol"],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=Gadovist","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T01:20:03.781688+00:00"},"timeline":{"url":"https://en.wikipedia.org/wiki/Gadovist","method":"deterministic","source":"Wikipedia","rawText":"","confidence":0.8,"sourceType":"wikipedia","retrievedAt":"2026-04-20T01:20:11.994857+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T01:20:10.649732+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=Gadovist","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T01:20:11.448139+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2218860/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T01:20:11.905685+00:00"}},"offLabel":[],"timeline":[],"_dailymed":null,"ecosystem":[],"mechanism":{},"_scrapedAt":"2026-03-27T23:31:01.679Z","_scrapedBy":"cloudflare-swarm","_wikipedia":{"url":"https://en.wikipedia.org/wiki/Gadobutrol","title":"Gadobutrol","extract":"Gadobutrol is a gadolinium-based MRI contrast agent (GBCA). It received marketing approval in Canada and the United States. As of 2007, it was the only GBCA approved at 1.0 molar concentrations."},"references":[],"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:20:13.842395+00:00","fieldsConflicting":0,"overallConfidence":0.95},"biosimilars":[],"competitors":[],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"indications":{"approved":[{"name":"Magnetic resonance imaging","diseaseId":"magnetic-resonance-imaging","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT06854458","phase":"NA","title":"The Multicenter Stress Cardiac Magnetic Resonance Quantitative Perfusion Imaging in the United States Study","status":"RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2025-06-27","conditions":"Ischemic Heart Disease (IHD), Cardiac Magnetic Resonance Imaging, Myocardial Blood Flow","enrollment":1000},{"nctId":"NCT03730051","phase":"PHASE4","title":"Dotarem vs Gadobutrol Contrast for Breast MRI","status":"COMPLETED","sponsor":"University of Massachusetts, Worcester","startDate":"2021-03-01","conditions":"Breast Diseases","enrollment":300},{"nctId":"NCT07472491","phase":"PHASE2, PHASE3","title":"A Phase 2/3 Study on the Efficacy and Safety of Mangaciclanol for Contrast-Enhanced MRI of CNS or Body in Adult Patients","status":"NOT_YET_RECRUITING","sponsor":"GE Healthcare","startDate":"2026-03-31","conditions":"Known or Highly Suspected Central Nervous System (CNS) Lesion, Known or Highly Suspected Body (Excluding CNS) Lesion","enrollment":640},{"nctId":"NCT03067467","phase":"","title":"Metabolic Characteristics of Brain Tumors Using Hyperpolarized Carbon-13 Magnetic Resonance Spectroscopic Imaging (MRSI)","status":"RECRUITING","sponsor":"University of Texas Southwestern Medical Center","startDate":"2019-06-01","conditions":"Brain Tumor Adult","enrollment":25},{"nctId":"NCT04893434","phase":"PHASE1","title":"Novel Imaging Technique to Assess Gynecologic Cancer","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2021-05-13","conditions":"Gynecologic Cancer","enrollment":20},{"nctId":"NCT07415018","phase":"NA","title":"Optimizing Contrast Dose and Scanning Parameters for Detection of Leptomeningeal Disease","status":"NOT_YET_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2026-07-22","conditions":"Leptomeningeal Disease","enrollment":40},{"nctId":"NCT07275814","phase":"PHASE3","title":"A Study of a Gadolinium-Based Contrast Agent (GBCA) for Adults Undergoing Magnetic Resonance Imaging (MRI) for Known or Highly Suspected Central Nervous System (CNS) Lesions","status":"RECRUITING","sponsor":"Shanghai Shengdi Pharmaceutical Co., Ltd","startDate":"2025-11-17","conditions":"For Contrast-enhanced Magnetic Resonance Imaging (MRI) of Central Nervous System (CNS) Lesions","enrollment":250},{"nctId":"NCT04373564","phase":"PHASE4","title":"Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years","status":"RECRUITING","sponsor":"Guerbet","startDate":"2021-03-24","conditions":"Motor Function, Cognitive Function, Contrast Media","enrollment":2076},{"nctId":"NCT07275723","phase":"PHASE3","title":"A Study of a Gadolinium-Based Contrast Agent (GBCA) for Adults Undergoing Magnetic Resonance Imaging (MRI) for Known or Highly Suspected Body Parts (Non-Central Nervous System) Lesions","status":"RECRUITING","sponsor":"Shanghai Shengdi Pharmaceutical Co., Ltd","startDate":"2025-11-14","conditions":"For Contrast-enhanced Magnetic Resonance Imaging (MRI) of Abnormal Vascular Lesions in Body Regions Excluding the Central Nervous System (CNS)","enrollment":306},{"nctId":"NCT04444128","phase":"","title":"IMPRoving Cardiovascular RiSk Stratification Using T1 Mapping in General populatION","status":"RECRUITING","sponsor":"Johann Wolfgang Goethe University Hospital","startDate":"2016-11-15","conditions":"Myocarditis, Heart Failure, Myocardial Fibrosis","enrollment":6000},{"nctId":"NCT05229744","phase":"","title":"Prevalence of Endolymphatic Hydrops With a Hitory of Congenital Cytomegalovirus Infection","status":"TERMINATED","sponsor":"Fondation Ophtalmologique Adolphe de Rothschild","startDate":"2022-12-15","conditions":"Endolymphatic Hydrops","enrollment":18},{"nctId":"NCT05915728","phase":"PHASE3","title":"A Study to Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Any Known or Suspected Problems of the Body (Except Brain or Spinal Cord-related Problems)","status":"COMPLETED","sponsor":"Bayer","startDate":"2023-07-24","conditions":"Contrast Enhancement in Magnetic Resonance Imaging, Non-central Nervous System Pathology","enrollment":404},{"nctId":"NCT02156739","phase":"NA","title":"Contrast-enhanced MRI in Detecting Benign and Malignant Liver Lesions","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2014-10-13","conditions":"Hepatocellular Carcinoma, Liver and Intrahepatic Bile Duct Disorder, Metastatic Malignant Neoplasm in the Liver","enrollment":100},{"nctId":"NCT04369560","phase":"EARLY_PHASE1","title":"Virtual Histology of the Bladder Wall for Bladder Cancer Staging","status":"RECRUITING","sponsor":"Jodi Maranchie","startDate":"2025-05-23","conditions":"Urinary Bladder Neoplasms","enrollment":42},{"nctId":"NCT07040865","phase":"PHASE4","title":"Randomized Comparison of Contrast Agents Gadopiclenol and Gadobutrol in the Workup of Incidental Renal and Adrenal Findings","status":"RECRUITING","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2025-08-18","conditions":"Suspect Renal and Adrenal Imaging Findings","enrollment":104},{"nctId":"NCT04219904","phase":"EARLY_PHASE1","title":"PET/MRI Scan for the Evaluation of Resectable Stage IA1-IB3 Cervical Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2018-09-07","conditions":"Stage IA Cervical Cancer, Stage IA1 Cervical Cancer, Stage IA2 Cervical Cancer","enrollment":25},{"nctId":"NCT03986138","phase":"PHASE3","title":"Efficacy and Safety of Gadopiclenol for Body Magnetic Resonance Imaging (MRI)","status":"COMPLETED","sponsor":"Guerbet","startDate":"2019-08-27","conditions":"Lesion in Body Region","enrollment":324},{"nctId":"NCT04910425","phase":"PHASE2","title":"PSMA-Targeted 18F-DCFPyL PET/MRI for the Detection of Prostate Cancer","status":"WITHDRAWN","sponsor":"Northwestern University","startDate":"2023-06-17","conditions":"Prostate Carcinoma","enrollment":""},{"nctId":"NCT05762367","phase":"NA","title":"MR Lymphatic Imaging in Idiopathic Intracranial Hypertention","status":"COMPLETED","sponsor":"Institut National de la Santé Et de la Recherche Médicale, France","startDate":"2023-03-10","conditions":"Idiopathic Intracranial Hypertension","enrollment":40},{"nctId":"NCT05783271","phase":"NA","title":"Validity of Parametric MRI Using VIRADS","status":"RECRUITING","sponsor":"Assiut University","startDate":"2025-12-01","conditions":"Bladder Cancer","enrollment":58},{"nctId":"NCT06265272","phase":"","title":"Value of [68Ga]Ga-PSMA-11 PET/MRI in the Assessment of Liver Cirrhosis","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2023-12-10","conditions":"Liver Cirrhosis, Hepatic Cell Carcinoma, Portal Hypertension","enrollment":45},{"nctId":"NCT03996447","phase":"PHASE3","title":"Efficacy and Safety of Gadopiclenol for Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)","status":"COMPLETED","sponsor":"Guerbet","startDate":"2019-06-03","conditions":"CNS Lesion, Blood Brain Barrier Defect","enrollment":260},{"nctId":"NCT06224543","phase":"PHASE1","title":"MR Image Synthesis With Low Gadobutrol Dose and AI","status":"COMPLETED","sponsor":"Subtle Medical","startDate":"2023-06-16","conditions":"Enhancing Brain Lesions","enrollment":60},{"nctId":"NCT05915702","phase":"PHASE3","title":"A Study to Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Known or Suspected Brain or Spinal Cord-related Problems","status":"COMPLETED","sponsor":"Bayer","startDate":"2023-07-24","conditions":"Contrast Enhancement in Magnetic Resonance Imaging, Central Nervous System Pathology","enrollment":303},{"nctId":"NCT03504956","phase":"NA","title":"Coronary Atherosclerosis T1-Weighted Characterization (CATCH)","status":"RECRUITING","sponsor":"Cedars-Sinai Medical Center","startDate":"2018-07-30","conditions":"Coronary Atherosclerosis","enrollment":150},{"nctId":"NCT05811377","phase":"EARLY_PHASE1","title":"Phenotyping Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) by Intravesical Contrast Enhanced - Magnetic Resonance Imaging (ICE-MRI) Bladder Permeability Assay","status":"COMPLETED","sponsor":"Christopher J Chermansky, MD","startDate":"2023-03-29","conditions":"IC - Interstitial Cystitis","enrollment":8},{"nctId":"NCT06846853","phase":"PHASE4","title":"Gadopiclenol vs. Gadobutrol for Dynamic Contrast-Enhanced Pituitary MRI (Magnetic Resonance Imaging)","status":"RECRUITING","sponsor":"UConn Health","startDate":"2025-03-01","conditions":"Contrast Enhanced Images vs. Non-contrast Images, Gadopiclinol Enhanced Images vs. Gadobutrol Enhanced Images","enrollment":10},{"nctId":"NCT04053842","phase":"PHASE2","title":"Multi-modality Imaging (PCa) Using Sodium MRI and PSMA PET in Men Pre-prostatectomy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Glenn Bauman","startDate":"2021-02-04","conditions":"Prostate Cancer, Prostate Adenocarcinoma, Prostate Neoplasm","enrollment":45},{"nctId":"NCT06797661","phase":"NA","title":"Insights Into the Pathophysiology of Neurovascular Uncoupling in Patients with Brain Lesions.","status":"RECRUITING","sponsor":"Erasme University Hospital","startDate":"2025-02-17","conditions":"Glioblastoma, Glioma, Astrocytoma","enrollment":40},{"nctId":"NCT05989022","phase":"NA","title":"Comparison of Low-dose Spiral Breast CT With MRI in Major Indications of MRI for Breast Diagnostics","status":"RECRUITING","sponsor":"AB-CT - Advanced Breast-CT GmbH","startDate":"2023-11-24","conditions":"Breast Cancer Diagnosis","enrollment":428},{"nctId":"NCT06735521","phase":"","title":"Cardiac Magnetic Resonance Stress-perfusion Study in Patinets with Fontan Circulation","status":"RECRUITING","sponsor":"Karolinska Institutet","startDate":"2024-04-15","conditions":"Univentricular Heart, Microvascular Dysfunction, Heart Failure","enrollment":30},{"nctId":"NCT05215132","phase":"PHASE4","title":"Investigational MRI Clinical Software and Hardware","status":"RECRUITING","sponsor":"Northwestern University","startDate":"2019-12-19","conditions":"Image, Body","enrollment":2000},{"nctId":"NCT06731829","phase":"PHASE2","title":"A Study for Adults Undergoing Magnetic Resonance Imaging (MRI) for Known or Highly Suspected Brain and/or Spinal Cord Conditions","status":"NOT_YET_RECRUITING","sponsor":"Jiangsu HengRui Medicine Co., Ltd.","startDate":"2024-12","conditions":"For Contrast-enhanced Magnetic Resonance Imaging (MRI) of Central Nervous System (CNS) Lesions","enrollment":78},{"nctId":"NCT05515874","phase":"PHASE4","title":"Predicting Stroke Risk in ICAD With Novel MRI","status":"RECRUITING","sponsor":"Northwestern University","startDate":"2021-08-16","conditions":"Intracranial Atherosclerosis","enrollment":100},{"nctId":"NCT05685160","phase":"NA","title":"US and MRI of the Forefoot: Intermetatarsal Bursitis or Morton's Neuroma","status":"ENROLLING_BY_INVITATION","sponsor":"Rigshospitalet, Denmark","startDate":"2021-06-14","conditions":"Intermetatarsal Bursitis, Morton Neuroma, Intermetatarsal Neuroma","enrollment":75},{"nctId":"NCT03937921","phase":"","title":"Dotarem Evaluation for Myocardial Perfusion CMR","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2019-07-03","conditions":"Myocardial Perfusion Imaging, Magnetic Resonance Imaging","enrollment":90},{"nctId":"NCT05250687","phase":"NA","title":"MR Guided Focused Ultrasound vs Radiotherapy for Palliative Pain Tx in Bone Metastases","status":"WITHDRAWN","sponsor":"Stanford University","startDate":"2024-06","conditions":"Bone Metastases","enrollment":""},{"nctId":"NCT05350189","phase":"","title":"A Study Called GUS to Understand How Much of the Contrast Agent Gadavist is Used and How Much is Wasted in Two Different Containers (Single-dose Vials and Imaging Bulk Packages ) in a Real-world Setting","status":"COMPLETED","sponsor":"Bayer","startDate":"2022-11-03","conditions":"Contrast Enhancement in Magnetic Resonance Imaging","enrollment":1602},{"nctId":"NCT02358811","phase":"","title":"Evaluation of the Impact of Sleep Apnea on Cerebral Volumetry According to Age","status":"TERMINATED","sponsor":"Centre Hospitalier Universitaire de Saint Etienne","startDate":"2015-06-30","conditions":"Obstructive Sleep Apnea (SAOS), Aging","enrollment":69},{"nctId":"NCT03389698","phase":"","title":"Developing Advanced Blood-Brain Barrier Permeability Imaging for Early AD","status":"COMPLETED","sponsor":"NYU Langone Health","startDate":"2018-12-18","conditions":"Alzheimer Disease","enrollment":27},{"nctId":"NCT00804128","phase":"","title":"Contrast-Enhanced MRI for the Characterization of Ductal Carcinoma in Situ (DCIS)","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2008-10-01","conditions":"Breast Cancer","enrollment":76},{"nctId":"NCT00375830","phase":"PHASE2","title":"Combined 18F-NaF/18F-FDG PET/MRI for Detection of Skeletal Metastases","status":"COMPLETED","sponsor":"Stanford University","startDate":"2006-01","conditions":"Cancer","enrollment":114},{"nctId":"NCT04307186","phase":"PHASE2","title":"Study to Find the Appropriate Dose of a New Gadolinium-based Contrast Agent (GBCA) for Adults Undergoing Magnetic Resonance Imaging (MRI) for Known or Highly Suspected Brain and/or Spinal Cord Conditions","status":"COMPLETED","sponsor":"Bayer","startDate":"2020-11-18","conditions":"Central Nervous System Pathology","enrollment":57},{"nctId":"NCT02540967","phase":"","title":"Drug Use Investigation of Gadovist.","status":"COMPLETED","sponsor":"Bayer","startDate":"2015-10-27","conditions":"Magnetic Resonance Imaging, Image Enhancement","enrollment":3357},{"nctId":"NCT04575636","phase":"NA","title":"MRL in the Upper Extremity","status":"COMPLETED","sponsor":"Maastricht University Medical Center","startDate":"2020-09-10","conditions":"Lymphedema of Upper Limb","enrollment":20},{"nctId":"NCT02095353","phase":"","title":"Comparison of Contrast Agents for MRI Perfusion Analysis in Brain Tumor Patients","status":"TERMINATED","sponsor":"University of Nebraska","startDate":"2014-09-01","conditions":"Central Nervous System Neoplasms","enrollment":6},{"nctId":"NCT04350957","phase":"NA","title":"Low-dose Imaging Technique (LITE)","status":"WITHDRAWN","sponsor":"University of Chicago","startDate":"2020-08-24","conditions":"Breast Cancer","enrollment":""},{"nctId":"NCT03064295","phase":"","title":"Whole-Heart Myocardial Blood Flow Quantification Using MRI","status":"UNKNOWN","sponsor":"Cedars-Sinai Medical Center","startDate":"2018-03-01","conditions":"Coronary Artery Disease, Coronary Microvascular Disease","enrollment":160},{"nctId":"NCT04132843","phase":"NA","title":"Novel MRI Techniques for the Characterization and Treatment Assessment of High Grade Brain Lesions","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2020-01-10","conditions":"Brain Neoplasm, Lymphoma, Metastatic Malignant Neoplasm in the Brain","enrollment":6},{"nctId":"NCT04096261","phase":"","title":"The Importance of Sleep Quality and the Blood-brain Barrier in Cognitive Disorders and Alzheimer's Disease","status":"WITHDRAWN","sponsor":"Charite University, Berlin, Germany","startDate":"2019-09-12","conditions":"Blood Brain Barrier Defect, Sleep Deprivation, Sleep Apnea","enrollment":""},{"nctId":"NCT03731819","phase":"NA","title":"Establishment of Abbreviated Pancreatobiliary MRI Protocol","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2018-11-05","conditions":"Pancreas Cyst, Intraductal Papillary Mucinous Neoplasm","enrollment":30},{"nctId":"NCT05293990","phase":"NA","title":"Usefulness of Gadovist-enhanced FLAIR Imaging","status":"COMPLETED","sponsor":"Ryoo, In Seon","startDate":"2017-02-02","conditions":"Malignant Tumors, Brain Lymphoma, CNS Lymphoma","enrollment":60},{"nctId":"NCT02917213","phase":"","title":"Imaging Silent Brain Infarct And Thrombosis in Acute Myocardial Infarction","status":"COMPLETED","sponsor":"Hospital General Universitario Gregorio Marañon","startDate":"2016-09","conditions":"Myocardial Infarction, Acute Disease, Thrombosis","enrollment":92},{"nctId":"NCT04093882","phase":"","title":"The Relevance of the Blood-brain Barrier to Cognitive Dysfunction and Alzheimer's Disease","status":"COMPLETED","sponsor":"Charite University, Berlin, Germany","startDate":"2019-09-12","conditions":"Blood Brain Barrier, Alzheimer Disease, Cognitive Dysfunction","enrollment":101},{"nctId":"NCT04949321","phase":"NA","title":"Acceleration of the Kinetics of Diffusion of Gadolinium in the Perilymphatic Structures of the Inner Ear.","status":"UNKNOWN","sponsor":"University Hospital, Grenoble","startDate":"2021-07-31","conditions":"Inner Ear ; Meniere's Disease; Imaging","enrollment":80},{"nctId":"NCT03602339","phase":"PHASE4","title":"Comparison of Gadovist 75% Standard Dose to Dotarem at Full Standard Dose","status":"COMPLETED","sponsor":"Bayer","startDate":"2018-11-14","conditions":"Magnetic Resonance Imaging","enrollment":157},{"nctId":"NCT00027170","phase":"","title":"Technical Development of Cardiovascular Magnetic Resonance Imaging","status":"COMPLETED","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"2001-11-26","conditions":"Cardiomyopathy, Congenital Heart Disease, Cardiovascular Disease","enrollment":8781},{"nctId":"NCT03404648","phase":"PHASE3","title":"Staging Prostate Cancer With Hybrid C11-Choline PET/MR and mpMRI","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2017-11-01","conditions":"Prostate Adenocarcinoma","enrollment":19},{"nctId":"NCT01544166","phase":"PHASE1","title":"Gadobutrol Pharmacokinetic and Safety Study in Pediatric Subjects Aged <2 Years (Term Newborn Infants to Toddlers 23 Months of Age Inclusive)","status":"COMPLETED","sponsor":"Bayer","startDate":"2012-05-16","conditions":"Magnetic Resonance Imaging","enrollment":44},{"nctId":"NCT01655290","phase":"PHASE2","title":"Comparison of Gadobutrol and Gadobenate Dimeglumin for Delayed Enhancement Cardiac MRI","status":"COMPLETED","sponsor":"Technical University of Munich","startDate":"2012-08","conditions":"Subacute/Chronic Myocardial Infarction","enrollment":20},{"nctId":"NCT04315584","phase":"EARLY_PHASE1","title":"FDG and FDOPA PET Demonstration of Functional Brain Abnormalities","status":"UNKNOWN","sponsor":"University of Virginia","startDate":"2020-03-15","conditions":"Glioblastoma","enrollment":5},{"nctId":"NCT01890434","phase":"PHASE3","title":"Gadobutrol / Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD)","status":"COMPLETED","sponsor":"Bayer","startDate":"2013-08-26","conditions":"Coronary Artery Disease","enrollment":478},{"nctId":"NCT03910114","phase":"","title":"Gadolinium-Based-Contrast-Agents (GBCA) Enhancement During MR Urography","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"1990-07-01","conditions":"Magnetic Resonance Imaging Contrast Agents","enrollment":500},{"nctId":"NCT03677466","phase":"NA","title":"Intramyocardial Haemorrhage in Patients With Primary STEMI","status":"COMPLETED","sponsor":"Tomsk National Research Medical Center of the Russian Academy of Sciences","startDate":"2018-01-25","conditions":"Myocardial Infarction, STEMI, Myocardial Necrosis","enrollment":60},{"nctId":"NCT03892681","phase":"NA","title":"Hepatocyte-specific Versus Extracellular Contrast Agents for Liver MRI: Prospective, Intra-individual Comparison of Diagnostic Performance for Hepatocellular Carcinoma","status":"UNKNOWN","sponsor":"Yonsei University","startDate":"2019-04","conditions":"Chronic Hepatitis, Liver Cirrhosis","enrollment":129},{"nctId":"NCT02135861","phase":"PHASE1","title":"A Method Validation Study for Evaluation of Novel Treatments Limiting Pulmonary Oedema in Cardiac Failure","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2014-07-30","conditions":"Heart Failure, Congestive","enrollment":41},{"nctId":"NCT02796729","phase":"PHASE2","title":"CEST- Glucose Enhanced MRI for Metastatic Brain Tumours","status":"TERMINATED","sponsor":"British Columbia Cancer Agency","startDate":"2016-10","conditions":"Brain Neoplasms, Malignant, Metastasis","enrollment":3},{"nctId":"NCT03057561","phase":"NA","title":"Efficacy of Dotarem® (Gd-DOTA) Versus Gadovist® (Gd-DO3A-butrol) for Late Gadolinium Enhancement Cardiac Magnetic Resonance","status":"UNKNOWN","sponsor":"Dipan Shah","startDate":"2016-10-01","conditions":"Coronary Artery Disease, Cardiomyopathy","enrollment":120},{"nctId":"NCT01344447","phase":"PHASE3","title":"Gadobutrol Enhanced MRA of the Supra-aortic Vessels","status":"COMPLETED","sponsor":"Bayer","startDate":"2011-05-12","conditions":"Carotid Stenosis","enrollment":479},{"nctId":"NCT02902588","phase":"NA","title":"Blood-brain Barrier Permeability Study in Adults With Meningitis","status":"TERMINATED","sponsor":"Nalecz Institute of Biocybernetics and Biomedical Engineering, Polish Academy of Sciences","startDate":"2015-08-01","conditions":"Blood-Brain Barrier Permeability","enrollment":20},{"nctId":"NCT01989000","phase":"NA","title":"The Role of the Tumor Microenvironment of Pancreatic Cancer to Predict Treatment Outcome","status":"COMPLETED","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2013-11","conditions":"Pancreatic Cancer","enrollment":47},{"nctId":"NCT01890421","phase":"PHASE3","title":"Gadobutrol/Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD)","status":"COMPLETED","sponsor":"Bayer","startDate":"2013-07-19","conditions":"Coronary Artery Disease","enrollment":426},{"nctId":"NCT02350426","phase":"PHASE1","title":"A Study to Assess Inflammation in Rheumatoid Arthritis Using Molecular Imaging Techniques","status":"TERMINATED","sponsor":"GlaxoSmithKline","startDate":"2015-08-12","conditions":"Arthritis, Rheumatoid","enrollment":10},{"nctId":"NCT00522951","phase":"PHASE3","title":"SH L 562BB Phase II/III Dose Justification and Gadoteridol-controlled Comparative Study","status":"COMPLETED","sponsor":"Bayer","startDate":"2007-08","conditions":"Brain Metastases","enrollment":165},{"nctId":"NCT02217280","phase":"NA","title":"Dispersal Pattern for Spine Injections (Gadolinium Contrast)","status":"COMPLETED","sponsor":"University of Missouri-Columbia","startDate":"2015-04","conditions":"Cervical Radiculopathy","enrollment":20},{"nctId":"NCT02967380","phase":"NA","title":"Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases","status":"TERMINATED","sponsor":"University of Southern California","startDate":"2011-12-14","conditions":"Adult Anaplastic (Malignant) Meningioma, Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma","enrollment":14},{"nctId":"NCT01995240","phase":"NA","title":"Functional Magnetic Resonance Imaging of Pancreatic Cancer: a Feasibility and Reproducibility Study","status":"COMPLETED","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2013-04","conditions":"Pancreatic Cancer","enrollment":23},{"nctId":"NCT02034708","phase":"PHASE4","title":"Efficacy Evaluation of Dotarem®-Enhanced MRI Compared to Gadovist®/Gadavist®-Enhanced MRI in the Diagnosis of Brain Tumors","status":"COMPLETED","sponsor":"Guerbet","startDate":"2014-06","conditions":"Primary Brain Tumor","enrollment":279},{"nctId":"NCT02294838","phase":"NA","title":"Feasibility Study of MRI Imaging on Parotid Gland Stimulation","status":"UNKNOWN","sponsor":"British Columbia Cancer Agency","startDate":"2014-12","conditions":"Parotid Neoplasms","enrollment":10},{"nctId":"NCT01575574","phase":"PHASE4","title":"Magnetic Resonance With Gadoxetic Acid for the Diagnosis of Hepatocellular Carcinoma in Patients With Liver Cirrhosis. Evaluation of Its Impact for the Non-invasive Diagnosis","status":"COMPLETED","sponsor":"Sara Varea","startDate":"2012-07","conditions":"Hepatocellular Carcinoma","enrollment":74},{"nctId":"NCT00828737","phase":"PHASE4","title":"Safety of Gadovist in Renally Impaired Patients","status":"COMPLETED","sponsor":"Bayer","startDate":"2008-12","conditions":"Fibrosis, Renal Impairment","enrollment":927},{"nctId":"NCT02655718","phase":"NA","title":"Short and Long Term Outcomes of Acute Coronary Syndrome in Patients With Non Obstructive Coronary Atherosclerosis","status":"UNKNOWN","sponsor":"Russian Academy of Medical Sciences","startDate":"2015-10","conditions":"Acute Coronary Syndrome","enrollment":200},{"nctId":"NCT02550951","phase":"NA","title":"Utility of MR Lymphangiography in Postoperative Follow-up of Lymphedema: Comparison With Lymphoscintigraphy","status":"UNKNOWN","sponsor":"Seoul National University Hospital","startDate":"2014-10","conditions":"Lymphedema","enrollment":7},{"nctId":"NCT01344460","phase":"PHASE3","title":"Gadobutrol Enhanced MRA of the Renal Arteries","status":"COMPLETED","sponsor":"Bayer","startDate":"2011-05","conditions":"Renal Artery Obstruction","enrollment":317},{"nctId":"NCT02274246","phase":"PHASE1","title":"Validation of the Efficacy of the Tool GIMIAS® for the Assessment of Left Atrial Fibrosis in a Group of Healthy Volunteers (RESTORE-HV)","status":"COMPLETED","sponsor":"Fundacion Clinic per a la Recerca Biomédica","startDate":"2014-11","conditions":"Left Atrial Fibrosis","enrollment":9},{"nctId":"NCT00468819","phase":"PHASE1","title":"A Study of Magnetic Resonance Imaging (MRI) With Gadavist in Children","status":"COMPLETED","sponsor":"Bayer","startDate":"2007-05","conditions":"Magnetic Resonance Imaging","enrollment":140},{"nctId":"NCT01613417","phase":"PHASE4","title":"Comparison of Prohance® With Gadovist®/Gadavist™ in Magnetic Resonance Imaging (MRI) of the Brain","status":"COMPLETED","sponsor":"Bracco Diagnostics, Inc","startDate":"2012-08","conditions":"Brain Disease","enrollment":229},{"nctId":"NCT00395460","phase":"PHASE3","title":"Efficacy and Safety Study to Evaluate Gadavist (Gadobutrol) as Contrast Agent in Magnetic Resonance Imaging (MRI) of Brain or Spine Diseases in Chinese Patients","status":"COMPLETED","sponsor":"Bayer","startDate":"2006-09","conditions":"Central Nervous System Diseases","enrollment":147},{"nctId":"NCT01095081","phase":"","title":"GARDIAN, Gadovist in Routine Diagnostic Magnetic Resonance Imaging Administration in Non-selected Patients","status":"COMPLETED","sponsor":"Bayer","startDate":"2010-07","conditions":"Magnetic Resonance Imaging, Magnetic Resonance Angiography","enrollment":23775},{"nctId":"NCT01050829","phase":"PHASE3","title":"Gadobutrol Magnevist-controlled Body Study","status":"COMPLETED","sponsor":"Bayer","startDate":"2010-01","conditions":"Magnetic Resonance Imaging","enrollment":370},{"nctId":"NCT00709852","phase":"PHASE3","title":"Safety and Efficacy of Gadobutrol 1.0 Molar (Gadavist) in Patients for Central Nervous System (CNS) Imaging","status":"COMPLETED","sponsor":"Bayer","startDate":"2008-06","conditions":"Diagnostic Imaging, Central Nervous System Diseases","enrollment":402},{"nctId":"NCT01836055","phase":"","title":"Imaging Multiple Sclerosis Lesions Using Magnevist and Gadavist","status":"TERMINATED","sponsor":"Wayne State University","startDate":"2012-01","conditions":"Multiple Sclerosis","enrollment":19},{"nctId":"NCT00764387","phase":"PHASE4","title":"Contrast Enhanced MRI of the CNS - Patients With Known Cerebral Neoplastic Lesions.","status":"COMPLETED","sponsor":"Bayer","startDate":"2008-03","conditions":"Neoplastic CNS Lesions","enrollment":166},{"nctId":"NCT01104584","phase":"PHASE3","title":"Efficacy and Safety of Gadobutrol 1.0 Molar (Gadovist) for Breast Magnetic Resonance Imaging (MRI)","status":"COMPLETED","sponsor":"Bayer","startDate":"2010-05","conditions":"Breast Cancer","enrollment":460},{"nctId":"NCT01067976","phase":"PHASE3","title":"Efficacy and Safety of Gadobutrol 1.0 Molar (Gadovist) for Breast MRI","status":"COMPLETED","sponsor":"Bayer","startDate":"2010-02","conditions":"Breast Cancer, Diagnostic Imaging","enrollment":446},{"nctId":"NCT01660841","phase":"PHASE3","title":"Safety and Efficacy of Gadobutrol 1.0 Molar in Japanese Subjects for CNS Imaging","status":"COMPLETED","sponsor":"Bayer","startDate":"2012-09","conditions":"Magnetic Resonance Imaging","enrollment":223},{"nctId":"NCT01490294","phase":"PHASE2","title":"Myocardial Perfusion MRI","status":"COMPLETED","sponsor":"Bayer","startDate":"2004-03","conditions":"Myocardial Perfusion Imaging, Magnetic Resonance Imaging","enrollment":232},{"nctId":"NCT00874640","phase":"","title":"Patient Characteristics in Daily Radiological Practice of Gadovist® Application (PATRON)","status":"COMPLETED","sponsor":"Bayer","startDate":"2009-03","conditions":"Epidemiologic Factors","enrollment":3711},{"nctId":"NCT00623467","phase":"PHASE3","title":"Safety and Efficacy of Gadobutrol 1.0 Molar ( Gadavist ) in Patients for Central Nervous System (CNS) Imaging","status":"COMPLETED","sponsor":"Bayer","startDate":"2007-12","conditions":"Central Nervous System Diseases","enrollment":343},{"nctId":"NCT02036008","phase":"NA","title":"Gadofosveset Trisodium (Ablavar, Gdfos) in Distinguishing Hemangiomas and Metastases: A Prospective Trial","status":"UNKNOWN","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2013-08","conditions":"Cancer, Metastases, Liver Neoplasms","enrollment":150}],"_emaApprovals":[],"_faersSignals":[{"count":139,"reaction":"DYSPNOEA"},{"count":126,"reaction":"NAUSEA"},{"count":83,"reaction":"DIZZINESS"},{"count":76,"reaction":"HEADACHE"},{"count":75,"reaction":"URTICARIA"},{"count":74,"reaction":"ERYTHEMA"},{"count":68,"reaction":"PRURITUS"},{"count":62,"reaction":"PARAESTHESIA"},{"count":56,"reaction":"VOMITING"},{"count":54,"reaction":"COUGH"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"crossReferences":{"chemblId":"CHEMBL2218860"},"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":155,"therapeuticAreas":["Other"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Gadovist","genericName":"Gadovist","companyName":"Vanderbilt University Medical Center","companyId":"vanderbilt-university-medical-center","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":1,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:20:13.842395+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}